Pilot Study of Valganciclovir-Induced Leukopenia in Kidney Transplant Recipients With NUDT15 Genetic Variation
Saved in:
| Main Authors: | Madan M. Bahadur, Nikhil Dhope, Rejitha R. Kaimal, Ashay Shingare |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-10-01
|
| Series: | Kidney International Reports |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024924018266 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Valacyclovir versus valganciclovir for cytomegalovirus prophylaxis in kidney transplant recipients: a systematic review and comparative meta-analysis
by: Leonardo Januário Campos Cardoso, et al.
Published: (2025-03-01) -
CMV Infection Risk Factors and Viral Dynamics After Valganciclovir Prophylaxis: 10 Years of Experience in Lung Transplant Recipients
by: Sarela García-Masedo Fernández, et al.
Published: (2024-11-01) -
PTPN2 and Leukopenia in Individuals With Normal TPMT and NUDT15 Metabolizer Status Taking Azathioprine
by: Laura L. Daniel, et al.
Published: (2025-06-01) -
Changes in Neutrophil Count During Valganciclovir Therapy for Symptomatic Congenital Cytomegalovirus Infection
by: Aoi Kawamura, et al.
Published: (2025-07-01) -
Adverse event profile differences between maribavir and valganciclovir: findings from the FDA adverse event reporting system
by: Haolin Teng, et al.
Published: (2025-05-01)